Condition: Atrial Fibrillation · Atrial Fibrillation, Persistent · Sponsor: Second Affiliated Hospital of Wenzhou Medical University
The purpose of this prospective randomized study is to assess whether a new treatment strategy consisting of circumferential Pulmonary vein isolation (PVI), left ROof linear (RL), Mitral Isthmus linear (MIL), and left anterior SEptal linear (ASL) ablation and left atrial appendage (LAA) Device occlusion (PROMISED procedure) is superior to the PVI combined LAA closure in enhancing the long-term success rate of catheter ablation in non-paroxysmal atrial fibrillation (AF) patients.
This description comes directly from the study's public registry record.
Yue-chun Li, MD · +86-0577-8567-6610 · liyuechun1980@sina.com
Yuan-nan Lin, MD · +86-0577-8567-6610 · 597049712@qq.com
Always discuss trial participation with your own doctor first.
| Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University | Wenzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06249347